-
CSCO BC | Academician Jinming Yu: Exploring New Directions in Breast Cancer Treatment and Empowering the Next Generation of Oncology Leaders
At the 2025 China National Breast Cancer Conference, CSCO President and Director of Shandong Cancer Hospital, Academician Jinming Yu, delivered a keynote address titled “Precision Integration of Radiotherapy and Immunotherapy in Breast Cancer.” His presentation explored not only the evolving role of radiotherapy in breast cancer treatment but also offered key insights into strengthening China’s…
-
Key Ingredients to Getting a Drug Combination Approved: Insights from Dr. Marjorie Green at ESMO TAT 2025
At ESMO TAT 2025, Dr. Marjorie Green, Senior Vice President and Head of Oncology at Merck, delivered a compelling presentation titled “Key Ingredients to Getting a Drug Combination Approved: Industry…
-
EBMT 2025 | Prof. Qingxiao Song: Breakthroughs in Steroid-Refractory GI-aGVHD and cGVHD
Prof. Qingxiao Song: At EBMT 2025, Professor Robert Zeiser from the University of Freiburg presented results from the STARGAZE trial—a multicenter, prospective Phase II study that, for the first time,…
-
EBMT 2025 | Prof. Yue Lu: CR and MRD Illuminate Prognosis in KMT2A-Rearranged Acute Leukemia
With the spring breeze of April sweeping through Florence, the 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT 2025) was successfully held from March 30…
-
EBMT 2025 | Prof. Yang Cao: Uncovering the Prognostic Impact of KRAS Mutations in KMT2A-Rearranged AML and Exploring Therapeutic Strategies
Prof. Yang Cao: KMT2A-rearranged acute myeloid leukemia (KMT2A-r AML), formerly known as MLL-rearranged AML, accounts for approximately 3% to 7% of newly diagnosed AML cases and represents a biologically and…
-
EBMT 2025 | Prof. Jun Ma: Spotlight on Cell and Gene Therapy as China’s Innovations Shine on the Global Stage
Hematology Frontier: Prof. Ma, welcome back to the EBMT Annual Meeting. What are your impressions this year? Are there any highlights that Chinese experts should pay particular attention to? Prof.…
-
EBMT 2025 | Prof. Jia Wei: Exploring Synergistic Mechanisms and Sequential Strategies in CAR-T Cell Therapy
Hematology Frontier: At this year’s EBMT Congress, your team presented three studies related to CAR-T therapy (A093, A134, A082). Among them, Study A093 showed that combining ASCT significantly improves long-term…
-
APASL Keynote Address | Academician Jiahong Dong: The Era of Precision Liver Surgery Powered by Smart Technology Has Arrived
Editor’s Note: On the morning of March 28, the 34th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2025) officially opened. During the keynote session, APASL 2025 Scientific Committee Chair, Academician Jiahong Dong of Beijing Tsinghua Changgung Hospital, delivered a keynote speech titled “Precision Surgical Treatment of Liver Diseases”…
Connecting Medical Expertise through Media